MoneyWorks4Me

With no major difference for the quarter endedMarch 2025 , the total revenue stood at Rs. 5277.80  millions.Net profit stood at Rs. 316.20  millions  compared to Rs. 281.90 millions in the corresponding previous quarter,high by 12.17%.The company reported a good operating profit of 674.60 millions compared to 576.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5277.80 5039.20 4.73 20792.10 21327.90 -2.51 20792.10 21327.90 -2.51
Other Income 45.20 75.20 -39.89 224.00 300.70 -25.51 224.00 300.70 -25.51
PBIDT 674.60 576.00 17.12 2245.70 2615.90 -14.15 2245.70 2615.90 -14.15
Interest 40.30 34.10 18.18 147.60 161.00 -8.32 147.60 161.00 -8.32
PBDT 634.30 541.90 17.05 2098.10 2454.90 -14.53 2098.10 2454.90 -14.53
Depreciation 185.30 164.20 12.85 719.20 628.50 14.43 719.20 628.50 14.43
PBT 449.00 377.70 18.88 1378.90 1826.40 -24.50 1378.90 1826.40 -24.50
TAX 132.80 95.80 38.62 368.90 472.20 -21.88 368.90 472.20 -21.88
Deferred Tax 62.20 45.60 36.40 121.50 102.10 19.00 121.50 102.10 19.00
PAT 316.20 281.90 12.17 1010.00 1354.20 -25.42 1010.00 1354.20 -25.42
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 12.78 11.43 11.82 10.80 12.27 -11.94 10.80 12.27 -11.94
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..